Viking Therapeutics (VKTX) Q1 2025 Earnings

5FebConfirmed
Q1 2024
Q3 2024
Q4 2024
Q1 2025
-0.32
-0.28
-0.24
-0.2

Details

Expected EPS
-0.275853
Actual EPS
-0.32
Surprise EPS
-0.04
Surprise Percent
+16%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.32 per share for Q1 2025.

0 Comments

Share your thoughts